Need a Reliable Peptide Supplier? Click HERE!!!SponsoredVisit ↗
Orforglipron and BAC Water Mix

Orforglipron Reconstitution Calculator

Enter the amount you want to measure. The vial buttons will highlight which vial strengths create cleaner syringe-unit measurements.

What amount do you need?

Type the target amount, then choose mg or mcg. Example: 2mg or 500mcg.

Work the dose out from body weight

Syringe size:
Possible vial strengths:
Best Match Good Match Usable Harder to Measure

Example Orforglipron Titration Schedule

StepDose StrengthDuration
1 — Start0.8 mg once dailyAt least 4 weeks
2 — Titration2.5 mg once dailyAt least 4 weeks
3 — Titration5.5 mg once dailyAt least 4 weeks
4 — Titration9 mg once dailyAs tolerated
5 — Titration14.5 mg once dailyAs tolerated
6 — Maximum17.2 mg once dailyMaintenance

FDA-approved (Foundayo, April 2026), the first oral non-peptide GLP-1. Steps 4–6 are optional — escalate by response and tolerability. Missed 7+ consecutive days: restart escalation at a lower dose. Do not combine with other GLP-1 drugs.

Possible vial strengths:

What Is It?

Orforglipron

Oral non-peptide GLP-1 receptor agonist.

Bacteriostatic Water

Sterile water containing a bacteriostatic preservative, commonly used when preparing multi-use research vials.

How To Mix Orforglipron

1
Clean

Use alcohol swabs to clean the tops of both vials.

2
Draw BAC Water

Draw the selected amount of bacteriostatic water.

3
Inject Slowly

Add the liquid slowly down the side of the vial.

4
Swirl Gently

Do not shake. Swirl gently until dissolved.

5
Store Properly

Store as directed and protect from heat and light.

Best Practices & Common Mistakes

Best Practices

  • Use sterile technique.
  • Protect from light and heat.
  • Store refrigerated when appropriate.
  • Use clean syringe-unit math before measuring.

Common Mistakes

  • Confusing milligrams with milliliters.
  • Choosing an option with awkward decimal units.
  • Using too little liquid for very small measurements.
  • Shaking the vial aggressively.

Orforglipron Storage & Handling

Lyophilized Powder: −20°C (−4°F) for long-term storage (up to 24 months). Refrigeration 2–8°C (36–46°F) for short-term use (up to ~3 months). Original sealed vial in the freezer is safest.
Reconstituted Solution: 2–8°C (36–46°F), use within ~7–14 days. Keep sealed, avoid light, and do not repeat freeze-thaw cycles.

Frequently Asked Questions

It's a once-daily oral GLP-1 receptor agonist from Eli Lilly, now sold under the brand name Foundayo. Unlike injectable GLP-1s, it's a small-molecule pill (not a peptide), so it isn't reconstituted, mixed, or injected — you swallow a tablet. It's also the first GLP-1 pill that can be taken any time of day without food or water restrictions.
Yes. The FDA approved it on April 1, 2026 as Foundayo, for adults with obesity or overweight with a weight-related condition, used alongside diet and exercise. That makes it one of the first oral GLP-1 options for weight management, after oral semaglutide (the Wegovy pill) was approved in December 2025.
Foundayo is a once-daily tablet taken at the same time each day, with or without food. The approved dose ladder steps up gradually — 0.8, 2.5, 5.5, 9, 14.5, up to a 17.2 mg maintenance dose — to ease stomach side effects. Because it's a fixed-strength pill, there's no measuring or mixing involved; the exact schedule is set by a prescriber.
No. Tirzepatide (Mounjaro/Zepbound) is an injectable peptide that acts on two receptors (GLP-1 and GIP). Orforglipron is an oral, non-peptide pill that acts on GLP-1 only. They're different molecules in different formats — orforglipron isn't an oral version of tirzepatide, even though both come from Eli Lilly.
Yes — orforglipron is one of the first. Most GLP-1 drugs are peptides that stomach acid breaks down, so they're injected; orforglipron is a small molecule that survives digestion, which is why it works as a daily tablet. Oral semaglutide (the Wegovy pill) is another oral option. A pill format means no needles, vials, or reconstitution at all.
Practical takeaway: If your goal involves weight management, metabolic health, recovery, physical performance, cognitive function, appearance, or general well-being, discuss it with a licensed healthcare professional. They can help you evaluate approved, evidence-based options rather than relying on an unapproved or investigational compound. This calculator is intended only for transparent research-reference calculations and does not determine an appropriate amount, recommend use, or replace professional medical guidance.

About the author

Maria Hrabina is a pharmacist and scientific reviewer with a strong interest in peptide science, pharmacology, and emerging therapeutic compounds.

Her work focuses on understanding how peptide-based compounds interact with biological signaling pathways and how they are being investigated across areas such as metabolic health, dermatology, recovery, regenerative research, and pharmaceutical development.

Maria follows research on a broad range of peptides, from compounds used in approved medicines to experimental molecules still being evaluated in laboratory, preclinical, and clinical studies.

Her approach combines scientific curiosity with critical evaluation of evidence. She believes promising mechanisms and early research deserve attention, but should not be presented as established clinical benefits until they are supported by adequate human data.

Her areas of focus include scientific literature review, mechanisms of action, pharmacology, pharmacokinetics, safety, pharmaceutical formulation, and the overall quality of evidence behind peptide-based compounds.

She is particularly interested in the process of translating an experimental molecule into a reliable pharmaceutical product — including compound characterization, purity, stability, formulation, dose selection, safety assessment, and controlled clinical trials.

Maria believes peptide science has significant long-term potential, but that its progress depends on rigorous research, high manufacturing standards, transparent safety data, and responsible scientific communication.

Through her writing, she aims to help readers understand both sides of peptide research: what makes these compounds scientifically promising and what questions remain before their potential can be considered clinically established.

Areas of interest: Peptide Science · Therapeutic Peptides · Peptide Pharmacology · Metabolic Peptides · Cosmetic Peptides · Drug Development · Pharmacokinetics · Drug Safety · Pharmaceutical Formulation · Emerging Therapies · Evidence-Based Medicine

Important: This tool is for informational and research-reference purposes only. Not intended for human or veterinary use.
← All peptides